GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021)
GeneDx Holdings (WGS) posted quarterly Preferred Stock Liabilities of $334.4 million for Q2 2021, up 54.04% year-over-year from $217.1 million in Q2 2020, and little changed quarter-over-quarter from $334.4 million in Q1 2021.
GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has reported Preferred Stock Liabilities for 2 consecutive years, with $334.4 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Preferred Stock Liabilities rose 54.04% year-over-year to $334.4 million; the TTM figure through Jun 2021 stood at $334.4 million (up 54.04% YoY), while the FY2020 annual figure was $334.4 million, up 54.04% from the prior year.
- Preferred Stock Liabilities held at $334.4 million in Q2 2021 per WGS's latest filing, from $334.4 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $334.4 million in Q3 2020 and bottomed at $217.1 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 334.44 Mn |
| Mar 31, 2021 | 334.44 Mn |
| Dec 31, 2020 | 334.44 Mn |
| Sep 30, 2020 | 334.44 Mn |
| Jun 30, 2020 | 217.12 Mn |